TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| S | %ret | 1 | 1 | 3 | -0 | 1 | 24 | 9 | 9 | 0 | 8 |
| S | %wins | 100 | 33 | 0 | 0 | 0 | 27 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
8/24/20 18:21 | 8/21/20 | TBPH | Theravance Biopharma, Inc. | E9 | Health | Drug | Pharmaceutical Preparations | Haumann Brett K | CA | O | Chief Me | S | -457 | 18.29 | 0 | -25 | -8 | 283 | D | ||||||||||||||
3/8/17 18:11 | 3/6/17 | TBPH | Theravance Biopharma, Inc. | E9 | Health | Drug | Pharmaceutical Preparations | Haumann Brett K | CA | O | SVP Clin | S.m | -441 | 31.50 | 7 | -14 | -8 | 163 | D | 51 | 68 | 6 | 6 | 5 | -6 | 0 | -3 | 0 | -2 | 15 | |||
8/25/16 19:34 | 8/25/16 | TBPH | Theravance Biopharma, Inc. | E9 | Health | Drug | Pharmaceutical Preparations | Haumann Brett K | CA | O | SVP Clin | S | -126 | 27.99 | 6 | -4 | -2 | 188 | D | -4 | 129 | 71 | 25 | 19 | 14 | -1 | -1 | 0 | 1 | 28 | 3 | 8 | |
8/23/16 19:23 | 8/19/16 | TBPH | Theravance Biopharma, Inc. | E9 | Health | Drug | Pharmaceutical Preparations | Haumann Brett K | CA | O | SVP Clin | S | -266 | 27.97 | 6 | -10 | -5 | 193 | D | -3 | 106 | 89 | 30 | 13 | -1 | 4 | -3 | -1 | 3 | 28 | 15 | 10 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |